Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease Post author: Post published: April 25, 2024 Post category:uncategorized Funding represents the first time the foundation has taken an equity position in a breath diagnostics company. You Might Also Like Global health burden of neurological conditions is much greater than previously understood, study reveals March 18, 2024 Scientists identify Bidara leaf extracts as the most effective natural antimicrobial source October 22, 2025 Exploring the anticancer potential of medicinal plants November 8, 2024
Global health burden of neurological conditions is much greater than previously understood, study reveals March 18, 2024
Scientists identify Bidara leaf extracts as the most effective natural antimicrobial source October 22, 2025